At iGEM, safety and security are paramount to ensuring responsible research and innovation. It is our responsibility to safeguard ourselves, our colleagues, our communities, and the environment from potential harm by adhering to stringent safety protocols and procedures, conducting risk assessments, and fostering a culture of awareness and precaution.
This page outlines the key safety protocols and procedures followed by our team members throughout the project. Our approach to safety encompasses safe laboratory practices, safe organisms, safe materials, and considerations of the applications and potential misuse of our project.
For detailed information on our safety procedures, please refer to our safety form here.
All laboratory experiments were conducted in a Biosafety Level 2 laboratory provided by our PI, Dr. Benjamin Bartelle, and iGEM team members only handled Risk Group 1 Biological Materials.
Before beginning, all wet lab team members were required to complete several training courses provided by ASU Environmental Health and Safety (EHS), the PI, and senior lab members. For the following sections, click on each button to learn more about the courses we took!
Throughout the cycle, printed protocols were readily accessible next to our lab bench. Before performing experiments, team members ensured that either the PI or a senior lab member was present, and no one worked alone.
All organisms used in our project can be found on the White List. Specifically, the team used:
All proteins used in our project can be found on the White List. Specifically, the team used:
All our genes were sourced from peer-reviewed journal articles, and our experimental materials were obtained from iGEM, IDT, and NEB.
Detailed protocols for our experimental procedures can be found here.
For gel purification, the team opted to use SYBR Safe DNA Gel Stain instead of the more commonly used ethidium bromide. Ethidium bromide is a known carcinogen and poses significant health risks in humans. SYBR Safe offers a safer alternative by reducing exposure to the highly mutagenic ethidium bromide and eliminating the need for harmful UV light for visualization.
Since OptoPACE was designed with the specific intent of making protein engineering more accessible, we prioritized reaching out to its potential end users to ensure the safety and security of our project.